Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Institute Of Microbiology Chinese Academy Of Sciences has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 2 examiners in 2 art units, reflecting two distinct examination paths.
DABKOWSKI, ERINNE R is the busiest examiner, with 1 pending matter. The balanced assignment supports separate matter review, while any common technical theme should be tested against the different examiner and art-unit contexts before adopting a unified response.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (67%) |
| §103 only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DABKOWSKI, ERINNE R | 1 | 55.8% | +68.7% |
| IANNUZO, NATALIE NMN | 1 | 12.2% | +71.4% |
| DURYEE, ALEXANDER MARSH | 1 | 33.3% | +41.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18441563 | POLYPEPTIDE FOR RESISTING NOVEL CORONAVIRUS AND APPLICATION THEREOF | DABKOWSKI, ERINNE R | — |
| 17635178 | APPLICATION OF BRANCHED-CHAIN A-KETOACID DEHYDROGENASE COMPLEX IN PREPARATION OF MALONYL COENZYME A | IANNUZO, NATALIE NMN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17611992 | METHOD FOR IMPROVING PRODUCTION OF STREPTOMYCES POLYKETIDE COMPOUNDS | DURYEE, ALEXANDER MARSH | 47d |
| 18441563 | POLYPEPTIDE FOR RESISTING NOVEL CORONAVIRUS AND APPLICATION THEREOF | DABKOWSKI, ERINNE R | — |
| 17635178 | APPLICATION OF BRANCHED-CHAIN A-KETOACID DEHYDROGENASE COMPLEX IN PREPARATION OF MALONYL COENZYME A | IANNUZO, NATALIE NMN | — |
| Art Unit | Apps |
|---|---|
| 1654 | 1 |
| 1653 | 1 |
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18441563 | POLYPEPTIDE FOR RESISTING NOVEL CORONAVIRUS AND APPLICATION THEREOF | DABKOWSKI, ERINNE R | 1654 | §101§102§112Other | Non-Final OA | — | Pending | Feb 14, 2024 |
| 17635178 | APPLICATION OF BRANCHED-CHAIN A-KETOACID DEHYDROGENASE COMPLEX IN PREPARATION OF MALONYL COENZYME A | IANNUZO, NATALIE NMN | 1653 | §101§103§112 | Final Rejection | — | Pending | Jul 22, 2022 |
| 17611992 | METHOD FOR IMPROVING PRODUCTION OF STREPTOMYCES POLYKETIDE COMPOUNDS | DURYEE, ALEXANDER MARSH | 1657 | §103 | Final Rejection | 47d | Pending | Nov 17, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialInstitute Of Microbiology Chinese Academy Of Sciences has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Erinne R Dabkowski has the most, with 1 of Institute Of Microbiology Chinese Academy Of Sciences's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
